SCHEMBL4716132

SCHEMBL4716132

Cc1nc(Cl)cc(-c2ccc(C(F)(F)F)cc2)n1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAD51 Q06609 1/20 0.48
ADORA3 P0DMS8 1/20 0.43
CTSS P25774 1/20 0.43
CTSK P43235 1/20 0.43
TOP1 P11387 2/20 0.42
CASP1 P29466 1/20 0.41
LMNA P02545 2/20 0.41
THRB P10828 1/20 0.41
KIF11 P52732 1/20 0.40
ALOX5 P09917 1/20 0.40
S1PR1 P21453 1/20 0.40
S1PR3 Q99500 1/20 0.40
TP53 P04637 1/20 0.40
KDM4E B2RXH2 2/20 0.40
ALDH1A1 P00352 1/20 0.40
HSD17B10 Q99714 1/20 0.40
PDE2A O00408 1/20 0.39
CXCL12 P48061 1/20 0.38
HSP90AA1 P07900 1/20 0.38
HSP90AB1 P08238 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1013065 0.85 ALDH1A1 (0.42) LMNAKIF11TP53KDM4EALDH1A1
SCHEMBL1844483 0.83 RAD51 (0.51) RAD51ADORA3CTSSCTSKTOP1
SCHEMBL16804872 0.83 RAD51 (0.47) RAD51ADORA3CTSSCTSKTOP1
SCHEMBL28879162 0.83 ADORA3 (0.52) RAD51ADORA3CTSSCTSKTOP1
SCHEMBL4619849 0.83 ALDH1A1 (0.46) RAD51ADORA3CTSSCTSKTOP1
SCHEMBL600729 0.81 RAD51 (0.44) RAD51ADORA3TP53KDM4EALDH1A1
SCHEMBL2848055 0.81 RAD51 (0.48) RAD51ADORA3CTSSCTSKTOP1
SCHEMBL4748830 0.80 MAPT (0.55) ADORA3LMNATP53KDM4EALDH1A1
SCHEMBL1643582 0.80 KDM4E (0.62) TOP1CASP1THRBKIF11KDM4E
SCHEMBL7873581 0.80 KDM4E (0.49) RAD51ADORA3CTSSCTSKTOP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7442701-B2 Amino-heterocycles as VR-1 antagonists for treating pain MERCK SHARP & DOHME LTD. (GB) 2008-10-28 US disclosed
EP-1562934-B1 AMINO-HETEROCYCLES AS VR-1 ANTAGONISTS FOR TREATING PAIN MERCK SHARP & DOHME (GB) 2008-03-26 EP disclosed
US-20060040947-A1 Amino-heterocycles as vr-1 antagonists for treating pain MERCK SHARP & DOHME LTD. (GB) 2006-02-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060040947-A1 Amino-heterocycles as vr-1 antagonists for treating pain OPRL1, CNR1, GPR6 RAD51 889/4885ADORA3 285/4885CTSS 4539/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.